Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
The Bottled Bartender is a manufacturer of premium RTD cocktails. The company manufactures, markets, and distributes single-serve premium cocktails to the trade, events and home markets. The cocktails are designed with the same recipes as a high-end bar, by using only branded spirits, garden-fresh ingredients made by the experienced staff. The company wants Trade and Events to benefit from the speed of service and logistical ease and not hire specialist staff. The Bottled Bartender anticipates in using a 24-hour courier service.
days to go:
Expired
investment:
£61,150
A money transfer service allowing customers to send money worldwide at a lower cost compared to traditional methods. TransferGo has been gaining 1,000 customers a day since May 2018 and currently has over 700,000 users. They have processed almost £781m on their platform through 1.3m transactions and operate on a gross profit margin of 6.7%.
TransferGo has 5 offices located in London, Berlin, Istanbul, Warsaw and Vilnius, with more than 100 employees globally. The company recently launched their new product, dubbed 'NOW', that enables users to send and receive monies in less than 30 minutes across borders.
Revenue is generated via fixed transfer fees and currency conversion fees ranging from 0.0% to 2.2% per transaction. These fees are dependent on the currency's origin and the amount being transferred. A free option is available to customers whose transaction may take a couple of days to transfer.
Funds are being raised to expand the business into emerging markets and introduce new products and services. This also means that TransferGo is aiming to provide local-language support and build new partnerships to attract more customers to their platform.
days to go:
Expired
investment:
£11,297,362
MyT is a cloud-powered subscription-based accounting software designed for small businesses that allows them to submit financial information to Her Majesty's Revenue and Customs (HMRC) under the Making Tax Digital initiative, which is mandatory from April 2023. MyT asserts that its app provides businesses with a simple way to keep track of business finances on the go, send and manage invoices and bills, and record expenses and mileage. The company claims that its app is available on App Store and Google Play and has witnessed 1000+ downloads to date. It claims that it has onboarded over 500 users without any extensive marketing spend. MyT will use half of the investment to implement its marketing plan, a third for developing new technology and the remaining for administrative expenses.
days to go:
Expired
investment:
£133,543
Propio offers The Property ISA, a tax-efficient, simple and affordable way to invest in properties. The company aims to become the UK’s largest property-based ISA by making the experience of investing as straightforward as online shopping. Propio is powered by a team of property and finance heavyweights who hand-select all the investments, helping the customers reduce risks and earn stable, tax-free returns, irrespective of market fluctuation. The company’s client base comprises 1000+ customers who have invested over £7.5m in it. According to TrustPilot, Propio is among the top 10 investment companies in the UK, delivering average returns of 6.5% to investors, despite Brexit and stock market turmoil. Moreover, the company has partnered with two UK finance and property firms and expects an investment deal flow of up to £100m by 2021-22.
days to go:
Expired
investment:
£357,660
B-North intends to revolutionise the business lending industry, which is often outdated, impersonal and slow. The fintech company uses some of the most advanced cloud-based technology, coupled with face-to-face relationship teams to get the best lending solutions for borrowers and their businesses. The company is powered by a team with prior experience in starting and scaling challenger banks, and profitability is its focused goal. B-North has submitted the banking licence application, and the result is expected by 2020.
days to go:
Expired
investment:
£2,135,456
Doc2UK is a specialist UK medical recruitment and candidate support platform. Based in London, the platform places qualified doctors in the National Health Scheme (NHS) roles around the United Kingdom. The British Medical Association (2018) reported that patient care is at risk due to a critical shortage of doctors across multiple medical disciplines. At present, the UK only has 24 medical schools to fill this gap, whilst India, in comparison, has 468 medical schools, with 68,000 doctors graduating each year. Moreover, uncertainty about the status of EU nationals after Brexit, changes to immigration policies, and the impact of changing language testing requirements for international nurses have made this crisis worse. This situation necessitates recruiting doctors from overseas an important endeavour. This is where Doc2UK aims to become a key player and ensure that lack of medical personnel doesn't disrupt any medical services. The company is seeking an investment of up to £300,000 which will be used to develop the platform with more features, expand the team, marketing and sales.
days to go:
Expired
investment:
Withheld
